Patents by Inventor Guy GRIEBEL

Guy GRIEBEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND ESCITALOPRAM
    Publication number: 20090247585
    Abstract: A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen from (S)-(?)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts thereof and at least one second active ingredient chosen from (S)-(+)-1-[4-(3-(dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 8, 2009
    Publication date: October 1, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Guy GRIEBEL, Caroline COHEN, Caroline LOUIS, Lisa Ann ARVANITIS
  • PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND PAROXETINE
    Publication number: 20090247583
    Abstract: A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen from (S)-(?)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts thereof and at least one second active ingredient chosen from trans-(?)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 8, 2009
    Publication date: October 1, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Guy GRIEBEL, Caroline COHEN, Caroline LOUIS, Lisa Ann ARVANITIS
  • PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND A SELECTIVE SEROTONIN REUPTAKE INHIBITOR OR A SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITOR
    Publication number: 20090227632
    Abstract: A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen from (S)-(?)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts there and at least one second active ingredient chosen from selective serotonin reuptake inhibitors, serotonin/norepinephrine reuptake inhibitors and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 20, 2009
    Publication date: September 10, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Guy GRIEBEL, Caroline COHEN, Caroline LOUIS, Lisa Ann ARVANITIS
  • PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND ESCITALOPRAM
    Publication number: 20080188526
    Abstract: A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen from (S)-(?)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts thereof and at least one second active ingredient chosen from (S)-(+)-1-[4-(3-(dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: July 30, 2007
    Publication date: August 7, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Guy Griebel, Caroline Cohen, Caroline Louis, Lisa Ann Arvanitis
  • PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND PAROXETINE
    Publication number: 20080188523
    Abstract: A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen front (S)-(?)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts thereof and at least one second active ingredient chosen from trans-(?)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluoropheny)piperidine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: July 30, 2007
    Publication date: August 7, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Guy Griebel, Caroline Cohen, Caroline Louis, Lisa Ann Arvanitis
  • ASSOCIATION OF BETA3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC USE THEREOF
    Publication number: 20080182899
    Abstract: The invention concerns the association of at least one ?3 adrenergic receptor agonist (or ?3 agonist) with a monoamine reuptake inhibitor. The invention also concerns a pharmaceutical composition comprising the inventive association and its therapeutic use.
    Type: Application
    Filed: March 18, 2008
    Publication date: July 31, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Guy GRIEBEL, Jeanne STEMMELIN
  • PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND A SELECTIVE SEROTONIN REUPTAKE INHIBITOR OR A SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITOR
    Publication number: 20080033014
    Abstract: A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen from (S)-(?)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts there and at least one second active ingredient chosen from selective serotonin reuptake inhibitors, serotonin/norepinephrine reuptake inhibitors and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: July 30, 2007
    Publication date: February 7, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Guy Griebel, Caroline Cohen, Caroline Louis, Lisa Arvanitis
  • USE OF PHENYLETHANOLAMINOTETRALINES FOR PREPARING ANXIOLYTIC DRUGS
    Publication number: 20080033041
    Abstract: Use of at least one phenylethanolaminotetraline of general formula (I): wherein A represents a (C1-C4)alkylene group, and R is hydrogen or a (C1-C4)alkyl group, or one of its pharmaceutically acceptable salts, for the preparation of a drug for treating anxiety disorders.
    Type: Application
    Filed: January 5, 2007
    Publication date: February 7, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Guy Griebel, Filippo Drago, Daniele Consoli, Carmen Mazzola, Vincenzo Micale